Norway· NO-ID_70CBC3FF-032F-4684-A8D8-3A6587E98500
Artesunate Amivas
A artesunate product containing artesunate, registered in Norway by Amivas Ireland Limited. The same ATC class is registered in 12 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Artesunate is registered in 12 of 19 countries.
Countries holding a registration under ATC P01BE03 (artesunate), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Artesunate · ATC P01BE03
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- United Kingdom
The record
At a glance
FEST (Norway)- Active substance
- Artesunate
- Manufacturer
- Amivas Ireland Limited
- Country
- Norway (NO)
- ATC code
- P01BE03
- ATC class
- Artesunate
- Defined daily dose
- 0.28 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_70CBC3FF-032F-4684-A8D8-3A6587E98500
- no_varenummer0773922NOK 32606.1
- gtin5397316000004
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
106 interactions on record for artesunate.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Artesunate · interactions on record
106 records
- 2 severe
- 104 moderate
Most severe, free to view
- EluxadolineA07DA06severe
- GrazoprevirJ05AP11severe
- RolapitantA04AD14moderate
- EliglustatA16AX10moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Artesunate in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomArtesunate 110mg powder and solvent for solution for injection vialsImported (Ireland)
- BelgiumArtesunate Amivas 110 mgAmivas Ireland
- SpainARTESUNATO AMIVAS 110 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLEAmivas Ireland Limited
- IcelandArtesunate AmivasAmivas Ireland Limited
- PolandArtesunate AmivasAmivas Ireland Ltd
- SwedenArtesunate Amivas 110 mg Pulver och vätska till injektionsvätska, lösningAmivas Ireland Limited
- CzechiaARTESUNATE AMIVASAmivas Ireland Ltd, Waterford
- FinlandArtesunate AmivasAmivas Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Artesunate Amivas
- Liechtenstein · Artesunate Amivas
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/19d9fd17-4ea1-4a88-ac30-83d48075d42f GET /v1/drugs/19d9fd17-4ea1-4a88-ac30-83d48075d42f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver og væske til injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Artesunat",
"merkevare_id": "ID_70CBC3FF-032F-4684-A8D8-3A6587E98500",
"name_form_strength": "Artesunate Amivas pulv+væske til inj oppl 110 mg",
"prescription_group": "C"
}See everything about artesunate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.